Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06565481

Measurement Properties of Physical Function Assessments in Adults with Hemophilia Evaluating Reliability and Validity of Clinical Tests

Led by University of Zurich · Updated on 2025-01-14

50

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

Sponsors

U

University of Zurich

Lead Sponsor

E

ETH Zurich

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to validate the accuracy and reliability of clinical tests that measure different aspects of physical function in adults with hemophilia. Hemophilia treatment has improved, but affected individuals still face challenges like limited mobility, reduced strength, poor balance, and pain caused by repeated bleeding. The study addresses the need to confirm that these clinical assessments are suitable and effective for adults with hemophilia, as previous research mainly involved children or other conditions. The study evaluates six physical function tests: Short Physical Performance Battery, Unipedal Stance Test, Four Square Step Test, Timed Up and Go, 1 kg Arm Lift Test, and 30 Second Chair Stand Test. These assessments are already used in practice and are considered safe with minimal strain. The study will assess the reliability of these tests by repeating them after a minimum 48-hour break and will check their validity by comparing results with other health measures, such as the Short Form 36 and Hemophilia Joint Health Score. Participants will complete the physical function tests twice, with a gap of at least 48 hours between sessions. Researchers will monitor performance using these tests to understand their measurement properties. Participants must be adults with hemophilia who can walk independently for 20 meters. The study involves no drugs or medical devices and focuses on gathering reliable data to support better clinical assessments for people living with hemophilia.

CONDITIONS

Official Title

Measurement Properties in People with Hemophilia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed Hemophilia Types A or B
  • Adults aged 18 years or older
  • Patients on prophylactic factor, non-factor replacement, or on-demand factor replacement treatment
  • Able to walk 20 meters independently, with or without a walking aid
  • Signed informed consent to participate in the study
Not Eligible

You will not qualify if you...

  • Severe cardiovascular, pulmonary, neurological, or musculoskeletal diseases
  • Unable to perform the assessments due to disability or language problems

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ruud Knols

Zurich, Switzerland, 8091

Actively Recruiting

Loading map...

Research Team

R

Ruud H Knols, PhD

A

Andrea Baerlocher, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

Study Comparing NXT007 and Emicizumab Prophylaxis in People ...

Hemophilia A

Actively Recruiting

6 locations

Study to Compare NXT007 and Factor VIII Prophylaxis in Peopl...

Hemophilia A

Actively Recruiting

2 locations

An Open-Label Study of Weekly Marstacimab Injections for Ped...

Hemophilia A

Actively Recruiting

34 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here